Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
Ontology highlight
ABSTRACT: Visceral leishmaniasis (VL) and Chagas disease (CD) are caused by kinetoplastid parasites that affect millions of people worldwide and impart a heavy burden against human health. Due to the partial efficacy and toxicity-related limitations of the existing treatments, there is an urgent need to develop novel therapies with superior efficacy and safety profiles to successfully treat these diseases. Herein we report the application of whole-cell phenotypic assays to screen a set of 150,000 compounds against Leishmania donovani, a causative agent of VL, and Trypanosoma cruzi, the causative agent of CD, with the objective of finding new starting points to develop novel drugs to effectively treat and control these diseases. The screening campaign, conducted with the purpose of global open access
SUBMITTER: Roquero I
PROVIDER: S-EPMC6545338 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA